Treace Medical Concepts, Inc.
TMCI- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001630627
In the last 90 days, Treace Medical Concepts, Inc. insiders filed 1 open-market purchase and 0 sales; 116 institutions reported holding it in 13F filings for Q2 2026, worth $126.8M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Treace Medical Concepts, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 123 | 137 | +14 |
| Shares | 35.5M | 38.9M | +3.40M (+9.6%) |
| Value | $895.1M | $995.8M | +$100.6M (+11.2%) |
New holders (26)
Institutions that held Treace Medical Concepts, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (12)
Institutions that held Treace Medical Concepts, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Marshall Wace, LLP | 282,905 | $7.13M |
| Divisadero Street Capital Management, LP | 175,000 | $4.41M |
| Industrial Alliance Investment Management Inc. | 136,550 | $3.44M |
| Renaissance Technologies LLC | 75,600 | $1.90M |
| Quantbot Technologies LP | 22,883 | $576.4K |
| Arrowstreet Capital, Limited Partnership | 21,711 | $547.0K |
| Schonfeld Strategic Advisors LLC | 21,300 | $536.5K |
| XTX Topco Ltd | 10,511 | $264.8K |
| Gabelli & Co Investment Advisers, Inc. | 10,000 | $251.9K |
| Graham Capital Management, L.P. | 8,400 | $211.6K |
| Parkside Financial Bank & Trust | 325 | $8.19K |
| US Bancorp | 18 | $453 |